Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Nan Ge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5764-7054; OpenAlex author ID A5100752268. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. EUS-guided neurolysis as a translational approach to tumor-promoting innervation in pancreatic cancer. Last author DOI 10.1097/eus.0000000000000226↗
  2. Diagnostic value of endoscopic ultrasound in staging of pancreatic cancer. First author DOI 10.4251/wjgo.v17.i7.107670↗
  3. Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasound guidelines. Rare pancreatic tumors, … Co-author DOI 10.1097/eus.0000000000000056↗
  4. Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study. Co-author DOI 10.3389/fimmu.2023.1203459↗
  5. Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer. Co-author DOI 10.2147/cmar.s308809↗
  6. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. Co-author DOI 10.4251/wjgo.v13.i9.1164↗
  7. Preliminary investigation of the function of hsa_circ_0006215 in pancreatic cancer. First author DOI 10.3892/ol.2018.8652↗
  8. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. Co-author DOI 10.3748/wjg.v23.i47.8345↗
  9. Pilot trial of endoscopic ultrasound-guided interstitial chemoradiation of UICC-T4 pancreatic cancer. Co-author DOI 10.4103/2303-9027.117773↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Yang · 1 shared paper, 2025 · strength 0.54
  2. Christoph F. Dietrich · 1 shared paper, 2026 · strength 0.50
  3. Siyu Sun · 5 shared papers, 2012–2024 · strength 0.49
  4. Jintao Guo · 3 shared papers, 2012–2023 · strength 0.41
  5. Siyu Sun · 2 shared papers, 2021–2023 · strength 0.38
  6. Fan Yang · 1 shared paper, 2023 · strength 0.22
  7. Michael Hocke · 1 shared paper, 2024 · strength 0.17
  8. ChristophF Dietrich · 1 shared paper, 2024 · strength 0.17
  9. Mihai Rimbaș · 1 shared paper, 2024 · strength 0.17
  10. Wei On · 1 shared paper, 2024 · strength 0.17
  11. Kathleen Möller · 1 shared paper, 2024 · strength 0.17
  12. Manoop S. Bhutani · 1 shared paper, 2024 · strength 0.17
  13. Na Li · 1 shared paper, 2021 · strength 0.16
  14. Ping Zhu · 2 shared papers, 2017–2018 · strength 0.15
  15. Xinzhu Sun · 1 shared paper, 2021 · strength 0.14
  16. Sheng Wang · 2 shared papers, 2012–2017 · strength 0.11
  17. Fan Yang · 1 shared paper, 2017 · strength 0.07
  18. Xiang Liu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.